Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial

People with HIV (PWH) are at increased risk of developing active tuberculosis (TB), and anemia is a common complication in both conditions. Anemia in TB patients has been linked to immune activation, levels of inflammatory biomarkers in blood, and risk for HIV disease progression and death. In this study we show that anemia was associated with a more pronounced inflammatory profile in HIV-TB coinfected persons in a cohort of 159 individuals with advanced HIV disease (CD4 count < 100 cells/µL) recruited as part of a randomized clinical trial (NCT00988780). A panel of plasma biomarkers was assessed on plasma obtained prior to combination antiretroviral therapy (cART) initiation. We performed a series of multidimensional analyses including clinical variables and concentrations of inflammatory biomarkers to profile systemic inflammation of PWH with and without anemia. We observed that TB participants presented with moderately lower levels of hemoglobin than non-TB participants. These participants also presented a higher Degree of Inflammatory Perturbation (DIP) score, related to increased levels of IFN-γ and TNF. The DIP was associated with TB coinfection and anemia before cART initiation. Future mechanistic studies are warranted to assess the determinants of such associations and the implications on treatment outcomes.

[1]  B. Andrade,et al.  Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV , 2020, Frontiers in Immunology.

[2]  J. Ananworanich,et al.  An inflammatory composite score predicts mycobacterial IRIS in people with HIV and severe lymphopenia: A prospective international cohort study. , 2020, The Journal of infectious diseases.

[3]  H. Nakaya,et al.  Assessing the Impact of Sample Heterogeneity on Transcriptome Analysis of Human Diseases Using MDP Webtool , 2019, Front. Genet..

[4]  F. Cobelens,et al.  Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy , 2019, Scientific Reports.

[5]  M. Jansson,et al.  Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals , 2019, Open forum infectious diseases.

[6]  W. Liles,et al.  Von Willebrand Factor Adhesive Activity and ADAMTS13 Protease Activity in HIV-1-Infected Men , 2019, International journal of medical sciences.

[7]  T. Shen,et al.  Monocyte activation and cardiovascular disease in HIV infection , 2017, Cellular & Molecular Immunology.

[8]  M. Lederman,et al.  Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients , 2017, Journal of virus eradication.

[9]  R. Bollinger,et al.  C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings , 2015, PloS one.

[10]  M. Lederman,et al.  Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. , 2014, The lancet. HIV.

[11]  P. Tak,et al.  Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. , 2012, Journal of immunological methods.

[12]  R. Bosch,et al.  Anemia in adults with tuberculosis is associated with HIV and anthropometric status in Dar es Salaam, Tanzania. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  D. Boulware,et al.  Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. , 2011, The Journal of infectious diseases.

[14]  C. K. Kwan,et al.  HIV and Tuberculosis: a Deadly Human Syndemic , 2011, Clinical Microbiology Reviews.

[15]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[16]  C. Obirikorang,et al.  Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting , 2009, Journal of Biomedical Science.

[17]  J. Saukkonen,et al.  HIV Impairs TNF-α Mediated Macrophage Apoptotic Response to Mycobacterium tuberculosis1 , 2007, The Journal of Immunology.

[18]  M. Youle,et al.  Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretrovial therapy era: relationships with gender * , 2007, HIV medicine.

[19]  M. Saag,et al.  Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. , 2004, AIDS research and human retroviruses.

[20]  A. Mocroft,et al.  Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. , 1999, AIDS.

[21]  M. Lederman,et al.  Prognostic factors in acquired immunodeficiency syndrome , 1988, Journal of General Internal Medicine.

[22]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[23]  K. Kedzierska,et al.  The influence of cytokines, chemokines and their receptors on HIV‐1 replication in monocytes and macrophages , 2003, Reviews in medical virology.